Preceyes' surgical robot gains CE mark for use in vitreoretinal surgery

Preceyes announced that it received CE mark approval for its Preceyes surgical system R1.1, which is used to assist trained surgeons with certain tasks during vitreoretinal surgery in patients under local or general anaesthesia. CEO Gerrit Naus said "we will leverage the CE marking approval for further industrialisation of our technology and to access new markets outside of the EU in the near future."

According to Preceyes, the robotic assistant is controlled by the surgeon through "intuitive hand movements, and can perform multiple injection, peeling and tissue manipulation tasks." The company added that the system's robotic manipulator holds and positions a surgical instrument inside the eye, while the system is able to execute motion profiles, including limiting of instrument movement to avoid performing dangerous actions, aiming to avoid surgical complications.

Preceyes further noted that the technology allows surgeons to operate on structures down to 0.02 mm for prolonged time periods, which makes the system ideal for the "highly precise drug delivery requirements required by the rapidly developing field of gene therapy treatments." Marc de Smet, chief medical officer, noted that the system filters tremor, potentially extending the surgeon's operating room lifespan, adding that the system's ergonomic design and the ability to be used with 3D head-up displays can help reduce back pain for surgeons.

Naus added that "while we are focusing on vitreoretinal applications at the moment, we believe our versatile technology can be developed to assist surgeons in performing most surgical procedures in the eye."

Did you like this article?